ArticleFrontiers in psychiatry2026
Longitudinal association between insulin resistance and depressive symptoms in older adults: the mediating role of inflammation in the ELSA cohort.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insulin resistance (IR) has been implicated in depression, yet the dynamic interplay between concurrent changes in IR and depressive symptoms over time, and whether systemic inflammation mediates this relationship, remains unclear. Methods: Data were obtained from 3,404 older adults (aged ≥50 years) in the English Longitudinal Study of Ageing (ELSA) across Waves 2, 4, and 6. IR was assessed using the estimated glucose disposal rate (eGDR). Depressive symptoms were measured with the CES-D scale (0-8). C-reactive protein (CRP) was log-transformed as the mediator. Linear mixed models were used to assess the longitudinal association between changes in eGDR and CES-D score. Restricted cubic splines were applied to explore potential nonlinear dose-response relationships. Mediation analysis was conducted to test whether CRP mediated the association. Subgroup and sensitivity analyses were performed to evaluate the robustness of the findings. Results: In the overall population, eGDR was significantly associated with CES-D score (P = 0.003), with no evidence of nonlinearity (P = 0.074). The overall eGDR × time interaction was not significant (P = 0.349). When stratified by joint trajectories of eGDR and CES-D, significant eGDR × time interactions were observed in two groups: the decrease-increase group (eGDR declined and CES-D increased, β = -0.018, P < 0.001), and the increase-decrease group, (eGDR increased and CES-D decreased, β = 0.021, P < 0.001). CRP partially mediated the association, with an indirect effect of -0.00092 (95% CI: -0.00155 to -0.00042), accounting for 10.8% of the total effect. Subgroup and sensitivity analyses confirmed robustness. Conclusions: The longitudinal association between IR and depressive symptoms differs across developmental trajectories and appears to be partially mediated by systemic inflammation. Our findings suggest that improvements in insulin sensitivity are associated with a lower risk of depressive symptoms in older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.